These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32659769)

  • 1. Association of Testosterone Levels and Steroid 5-Alpha-Reductase 2 Polymorphisms with Opioid Craving.
    Janke E; Groh A; Mühle C; Dürsteler-MacFarland KM; Wiesbeck GA; Kornhuber J; Jahn K; Groeschl M; Lichtinghagen R; Frieling H; Bleich S; Hillemacher T; Lenz B; Heberlein A
    Neuropsychobiology; 2021; 80(1):64-73. PubMed ID: 32659769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of V89L SRD5A2 polymorphism with craving and serum leptin levels in male alcohol addicts.
    Lenz B; Schöpp E; Müller CP; Bleich S; Hillemacher T; Kornhuber J
    Psychopharmacology (Berl); 2012 Dec; 224(3):421-9. PubMed ID: 22707254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.
    Allen NE; Forrest MS; Key TJ
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):185-9. PubMed ID: 11303586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism.
    Shiota M; Fujimoto N; Yokomizo A; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):191-6. PubMed ID: 26857022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.
    Boer H; Westerink NL; Altena R; Nuver J; Dijck-Brouwer DAJ; van Faassen M; Klont F; Kema IP; Lefrandt JD; Zwart N; Boezen HM; Smit AJ; Meijer C; Gietema JA
    Eur J Cancer; 2016 Feb; 54():104-111. PubMed ID: 26751392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk.
    Kakinuma H; Tsuchiya N; Habuchi T; Ohyama C; Matsuura S; Wang L; Nakamura A; Kato T
    Prostate Cancer Prostatic Dis; 2004; 7(4):333-7. PubMed ID: 15477877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex dependent influence of a functional polymorphism in steroid 5-α-reductase type 2 (SRD5A2) on post-traumatic stress symptoms.
    Gillespie CF; Almli LM; Smith AK; Bradley B; Kerley K; Crain DF; Mercer KB; Weiss T; Phifer J; Tang Y; Cubells JF; Binder EB; Conneely KN; Ressler KJ
    Am J Med Genet B Neuropsychiatr Genet; 2013 Apr; 162B(3):283-292. PubMed ID: 23505265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men.
    Yu MW; Yang YC; Yang SY; Cheng SW; Liaw YF; Lin SM; Chen CJ
    J Natl Cancer Inst; 2001 Nov; 93(21):1644-51. PubMed ID: 11698569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of three polymorphisms in the steroid-5-alpha-reductase, alpha polypeptide 2 gene (SRD5A2) and risk of prostate cancer.
    Li X; Huang Y; Fu X; Chen C; Zhang D; Yan L; Xie Y; Mao Y; Li Y
    Mutagenesis; 2011 May; 26(3):371-83. PubMed ID: 21177315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
    Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
    Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between polymorphisms in sex steroid related genes and autistic-like traits.
    Zettergren A; Jonsson L; Johansson D; Melke J; Lundström S; Anckarsäter H; Lichtenstein P; Westberg L
    Psychoneuroendocrinology; 2013 Nov; 38(11):2575-84. PubMed ID: 23867117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of testosterone and BDNF serum levels with craving during alcohol withdrawal.
    Heberlein A; Lenz B; Opfermann B; Gröschl M; Janke E; Stange K; Groh A; Kornhuber J; Frieling H; Bleich S; Hillemacher T
    Alcohol; 2016 Aug; 54():67-72. PubMed ID: 27514572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population.
    Yamada Y; Watanabe M; Murata M; Yamanaka M; Kubota Y; Ito H; Katoh T; Kawamura J; Yatani R; Shiraishi T
    Int J Cancer; 2001 Jun; 92(5):683-6. PubMed ID: 11340572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [V89L polymorphism of the testosterone 5-alpha-reductase II gene and prognostic factors of prostate cancer].
    Tong M; Jin YY; Li G; Liu SM; Ji CD
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):990-3. PubMed ID: 21218640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypospadias risk and polymorphism in SRD5A2 and CYP17 genes: case-control study among Indian children.
    Samtani R; Bajpai M; Vashisht K; Ghosh PK; Saraswathy KN
    J Urol; 2011 Jun; 185(6):2334-9. PubMed ID: 21511288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of SRD5A2 gene mutations with risk of hypospadias in the Iranian population.
    Rahimi M; Ghanbari M; Fazeli Z; Rouzrokh M; Omrani S; Mirfakhraie R; Omrani MD
    J Endocrinol Invest; 2017 Apr; 40(4):391-396. PubMed ID: 27848231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients.
    Maimoun L; Philibert P; Cammas B; Audran F; Bouchard P; Fenichel P; Cartigny M; Pienkowski C; Polak M; Skordis N; Mazen I; Ocal G; Berberoglu M; Reynaud R; Baumann C; Cabrol S; Simon D; Kayemba-Kay's K; De Kerdanet M; Kurtz F; Leheup B; Heinrichs C; Tenoutasse S; Van Vliet G; Grüters A; Eunice M; Ammini AC; Hafez M; Hochberg Z; Einaudi S; Al Mawlawi H; Nuñez CJ; Servant N; Lumbroso S; Paris F; Sultan C
    J Clin Endocrinol Metab; 2011 Feb; 96(2):296-307. PubMed ID: 21147889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between sex-related hormones, alcohol dependence and alcohol craving.
    Ho AM; Geske JR; Bakalkin G; Winham SJ; Karpyak VM
    Drug Alcohol Depend; 2019 Apr; 197():183-190. PubMed ID: 30840924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.